glutathione glioblastoma depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo Frontiers | Metabolic Drivers of
Frontiers Metabolic Drivers of Invasion in Glioblastoma Glioblastoma (GBM): What It Is, Symptoms & Prognosis New findings shed light on selective therapeutics for IDH1 mutated glioma EurekAlert! Glioblastoma studies show promise UNC Chapel Hill
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

